International Clinical Trial: Mechanisms and Therapeutic Targeting of CD169? Osteomac-Driven Immuno-Neuronal Interactions in the Promotion of Osteoarthritis Pain

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115844) titled 'Mechanisms and Therapeutic Targeting of CD169? Osteomac-Driven Immuno-Neuronal Interactions in the Promotion of Osteoarthritis Pain' on Dec. 31, 2025.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Zhejiang Provincial People's Hospital

Condition: Osteoarthritis

Intervention: Lateral control region:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Lateral control region:10;Medial OA region:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=303395

Published by HT...